Facility-Level Case Report of Nursing Care Processes for Patients With Suspected 2019 Novel Coronavirus Disease in Shanghai, China.

It was a single-center study with 119 patients and a relatively small sample. It was retrospective and relied on clinical records and nursing notes. There was no comparison group or random assignment, so the care processes were not tested. Many infection-control, monitoring, educational, and medication measures were given together, so the contribution of any single component cannot be separated. The study did not account for false positive or negative laboratory results for confirming COVID-19. The report gives inconsistent medication counts, stating that all patients received ofloxacin while also stating antibiotics were used in 74 patients. No patients were severe enough to require intubation in the ward, so it says little about care for critically ill patients. The report did not follow patients after discharge to assess rehabilitation or psychological outcomes.

The authors reported no conflicts of interest. Funding came from hospital funds related to emergency nursing human resources and first-line nurse training.

Do not conclude that the nursing and infection-control processes prevented cross-infection. The paper was a descriptive report with no comparison group, and many processes occurred at once, so the absence of detected cross-infection cannot be credited to any single measure.